Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Marsh

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|November 26, 2019
National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the 'first 90' from program and survey dataMathieu Maheu-Giroux, Kimberly Marsh, Carla M Doyle, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
Wellcome Open Research|January 8, 2026
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus typeAnna Mensah, Rebecca Symes, Chengetai Mpamhanga, et al.
Journal of the International AIDS Society|September 21, 2021
Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort dataLeigh F Johnson, Azar Kariminia, Adam Trickey, et al.
The Lancet. HIV|August 11, 2020
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical modelsBritta L Jewell, Edinah Mudimu, John Stover, et al.
Journal of the Royal Society of Medicine|February 12, 2024
Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort studyTing Shi, Tristan Millington, Chris Robertson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Influenza and Other Respiratory Viruses|May 22, 2024
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United KingdomHeather Whitaker, Beth Findlay, Jana Zitha, et al.
Influenza and Other Respiratory Viruses|May 14, 2024
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great BritainHeather J Whitaker, Naoma Willam, Simon Cottrell, et al.
The Lancet Regional Health. Europe|May 8, 2026
Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case-control studies in England, Wales, Scotland, and Northern IrelandMagda Bucholc, Safraj Shahul Hameed, Simon Cottrell, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|November 26, 2019
National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the 'first 90' from program and survey dataMathieu Maheu-Giroux, Kimberly Marsh, Carla M Doyle, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
Wellcome Open Research|January 8, 2026
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus typeAnna Mensah, Rebecca Symes, Chengetai Mpamhanga, et al.
Journal of the International AIDS Society|September 21, 2021
Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort dataLeigh F Johnson, Azar Kariminia, Adam Trickey, et al.
The Lancet. HIV|August 11, 2020
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical modelsBritta L Jewell, Edinah Mudimu, John Stover, et al.
Journal of the Royal Society of Medicine|February 12, 2024
Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort studyTing Shi, Tristan Millington, Chris Robertson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Influenza and Other Respiratory Viruses|May 22, 2024
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United KingdomHeather Whitaker, Beth Findlay, Jana Zitha, et al.
Influenza and Other Respiratory Viruses|May 14, 2024
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great BritainHeather J Whitaker, Naoma Willam, Simon Cottrell, et al.
The Lancet Regional Health. Europe|May 8, 2026
Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case-control studies in England, Wales, Scotland, and Northern IrelandMagda Bucholc, Safraj Shahul Hameed, Simon Cottrell, et al.
Pageof 5